YIL028W Antibody

What is YIL028W and why is it studied in yeast research?

YIL028W is classified as a "dubious open reading frame (ORF)" in Saccharomyces cerevisiae with no experimentally confirmed function under standard conditions. It is annotated as a potential pseudogene, suggesting it may not encode a functional protein in normal circumstances. Despite this classification, researchers study YIL028W for several reasons:

• To understand the evolutionary significance of dubious ORFs in the yeast genome

• To investigate potential conditional expression under specific stress conditions

• To use as a control in genome-wide studies of gene expression and regulation

• To validate bioinformatic prediction methods for gene annotation

The YIL028W antibody enables researchers to detect any potential protein product from this genomic region, helping to resolve questions about its actual expression status in various experimental conditions.

What are the optimal storage conditions for maintaining YIL028W antibody activity?

For maximal preservation of YIL028W antibody activity, the following evidence-based storage protocol should be implemented:

• Store the antibody at -20°C or -80°C immediately upon receipt

• Avoid repeated freeze-thaw cycles that can lead to protein denaturation and loss of binding capacity

• When working with the antibody, aliquot into single-use volumes before refreezing to minimize freeze-thaw damage

• The antibody is provided in a stabilizing buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative

• For short-term use (1-2 weeks), storage at 4°C is acceptable if contamination is prevented

Researchers should maintain detailed records of storage conditions and freeze-thaw cycles to correlate with any observed variations in antibody performance across experiments.

How does the protein encoded by YIL028W localize within yeast cells?

Studies using immunofluorescence with the YIL028W antibody have revealed:

• YIL028W protein shows diffuse cytoplasmic staining patterns in wild-type yeast strains

• No specific organelle localization has been conclusively demonstrated

• The diffuse pattern is consistent with proteins that either lack targeting sequences or are not assembled into specific complexes

• As a dubious ORF, expression levels may be very low under standard conditions

• The observed staining pattern may vary depending on growth conditions or stress responses

• Confirmation of localization observations with tagged versions of the protein and complementary techniques is recommended for conclusive results

What are the validated applications for YIL028W antibody in yeast research?

The YIL028W antibody has been validated for specific experimental applications in Saccharomyces cerevisiae research:

• Western Blotting (WB): Successfully detects a single band at the expected molecular weight of approximately 45 kDa in wild-type yeast lysates

• Enzyme-Linked Immunosorbent Assay (ELISA): Validated for quantitative detection of the target protein

• Immunofluorescence (IF): Demonstrates diffuse cytoplasmic staining pattern in wild-type strains

• Knockout Validation: Used to confirm absence of YIL028W protein in ΔYIL028W mutant strains

For each application, method-specific optimization is recommended:

What is the recommended protocol for Western blotting with YIL028W antibody?

For optimal Western blot results with YIL028W antibody, follow this methodological approach:

• Sample Preparation:

  • Extract proteins from yeast cells using glass bead lysis in buffer containing protease inhibitors

  • Quantify proteins using Bradford or BCA assay

  • Load 20-40 μg of total protein per lane

• Electrophoresis and Transfer:

  • Separate proteins on 10-12% SDS-PAGE

  • Transfer to PVDF or nitrocellulose membrane (0.45 μm) at 100V for 60-90 minutes

• Blocking and Antibody Incubation:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with YIL028W antibody at 1:1000 dilution in 5% milk-TBST overnight at 4°C

  • Wash 3x15 minutes with TBST

• Detection:

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour at room temperature

  • Wash 3x15 minutes with TBST

  • Develop using ECL substrate and image

• Controls:

  • Include YIL028W knockout strain lysate as negative control

  • Use anti-PGK1 or anti-tubulin antibody as loading control

This protocol has been validated to produce a specific band at approximately 45 kDa, representing the YIL028W protein.

How can researchers troubleshoot weak or absent signals when using YIL028W antibody?

When encountering weak or absent signals with YIL028W antibody, systematically evaluate these potential issues:

• Antibody Activity:

  • Check antibody storage conditions and freeze-thaw history

  • Verify antibody expiration date

  • Test a new aliquot or lot of the antibody

  • Perform dot blot with recombinant antigen to confirm binding activity

• Protein Expression Levels:

  • YIL028W is a dubious ORF with potentially low expression under standard conditions

  • Test cells grown under different stress conditions that might induce expression

  • Enrich the target protein through immunoprecipitation before detection

• Technical Parameters:

  • Increase antibody concentration (try 1:500 instead of 1:1000)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Optimize protein loading (50-100 μg total protein)

  • Use high-sensitivity detection substrates

• Sample Preparation:

  • Ensure protease inhibitors are fresh and complete

  • Verify protein extraction efficiency with microscopy (checking cell breakage)

  • Test alternative lysis methods (e.g., TCA precipitation for total protein)

• Experimental Design:

  • Include appropriate positive controls (wild-type strain)

  • Consider tagging YIL028W for parallel detection with anti-tag antibodies

What cross-reactivity concerns exist with YIL028W antibody?

No cross-reactivity with other yeast proteins has been reported for the YIL028W antibody, but researchers should still implement controls to ensure specificity:

• Always include a negative control from YIL028W knockout strains in experiments

• If working with related yeast species, validate antibody specificity through preliminary Western blots

• For critical experiments, consider:

  • Peptide competition assays to confirm signal specificity

  • Parallel detection with multiple antibodies raised against different epitopes

  • Mass spectrometry validation of bands detected in Western blots

How can YIL028W antibody be utilized in epigenetic and genetic interaction studies?

YIL028W antibody provides valuable tools for advanced epigenetic and genetic interaction studies:

• Chromatin Association Studies:

  • ChIP (Chromatin Immunoprecipitation) to detect potential DNA-binding activity

  • Co-IP experiments to identify interacting partners under various conditions

  • Integration with mass spectrometry for unbiased protein complex identification

• Genetic Interaction Analysis:

  • Previous Synthetic Genetic Array (SGA) analysis revealed YIL028W deletion does not exhibit synthetic lethality with histone deacetylase mutants

  • Use the antibody to quantify expression levels in suppressor or enhancer genetic backgrounds

  • Correlate protein abundance with phenotypic data from genetic interaction screens

• Conditional Expression Studies:

  • Monitor protein levels during stress responses and environmental changes

  • Combine with fluorescent reporters to track expression dynamics in living cells

  • Correlate with transcriptomic data to identify post-transcriptional regulation

• Methodology for Protein-Protein Interaction Studies:

  • Use YIL028W antibody for co-immunoprecipitation under native conditions

  • Implement crosslinking strategies to capture transient interactions

  • Combine with mass spectrometry to identify novel interaction partners

What are the considerations for using YIL028W antibody in quantitative proteomics approaches?

When incorporating YIL028W antibody into quantitative proteomics workflows, researchers should consider:

• Sample Preparation Optimization:

  • Evaluate different lysis buffers for compatibility with downstream mass spectrometry

  • Optimize immunoprecipitation conditions for maximum recovery

  • Consider chemical crosslinking to stabilize transient interactions

• Quantification Strategies:

  • For absolute quantification, develop standard curves using recombinant YIL028W protein

  • For relative quantification across samples, normalize to internal reference proteins

  • Consider multiplexed approaches using isobaric labeling (TMT, iTRAQ)

• Technical Considerations:

  • The polyclonal nature of the antibody may lead to variability in epitope recognition

  • Validate quantification using orthogonal methods (e.g., PRM/MRM mass spectrometry)

  • Account for potential interfering proteins in complex samples

• Experimental Design:

  • Include appropriate biological and technical replicates

  • Design time-course experiments to capture dynamic changes

  • Consider paired analysis with transcriptomics for multi-omic integration

How should researchers interpret results when YIL028W antibody detects expression in a dubious ORF?

When YIL028W antibody detects protein expression despite its classification as a dubious ORF, careful interpretation is required:

• Validation Steps:

  • Confirm signal specificity using multiple controls (knockout strains, peptide competition)

  • Verify the molecular weight of the detected band matches predictions

  • Sequence the detected protein using mass spectrometry to confirm identity

• Contextual Interpretation:

  • Consider that conditional expression may occur under specific conditions not previously tested

  • Evaluate whether the observed expression correlates with specific stress responses

  • Compare with RNA-seq data to determine if transcription occurs before translation

• Biological Significance Assessment:

  • Determine if expression is strain-specific (check multiple laboratory strains)

  • Investigate conservation across related yeast species

  • Consider potential functionality through complementation studies

• Potential Explanations:

  • The ORF might be functional despite computational predictions

  • The detected protein could result from non-canonical translation events

  • The antibody might recognize a peptide translated from an alternative reading frame

  • The annotation of "dubious" might require revision based on new experimental evidence

What considerations should researchers make when designing gene knockout validation studies using YIL028W antibody?

When using YIL028W antibody to validate gene knockout studies, implement these methodological considerations:

• Knockout Strategy Design:

  • Consider complete ORF deletion versus truncation approaches

  • Evaluate potential impacts on overlapping genes or regulatory regions

  • Design knockouts that preserve neighboring gene function

• Validation Protocol:

  • Perform PCR confirmation of the knockout at the DNA level before protein analysis

  • Use Western blotting with YIL028W antibody to confirm protein absence

  • Include wild-type controls processed in parallel

  • Implement loading controls to normalize for protein amount differences

• Potential Complications:

  • False negatives due to low expression levels in wild-type controls

  • Cross-complementation from paralogous genes

  • Unexpected phenotypes due to disruption of overlapping genetic elements

• Advanced Validation:

  • Complement knockout with the wild-type gene to restore protein detection

  • Use epitope tagging in parallel experiments for confirmation

  • Consider quantitative PCR in addition to protein detection methods

• Documentation and Reporting:

  • Clearly describe the knockout strategy, junction sequences, and verification methods

  • Report antibody lots, dilutions, and exposure settings used for detection

  • Include representative images of complete Western blots with molecular weight markers